Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinical review of Sharon Osbourne's confirmed Ozempic use, her public account of excessive weight loss, and what her experience reveals about GLP-1 risks in older adults.
Read clinical reviewSharon Osbourne publicly confirmed Ozempic use and described losing what she called 'too much' weight. The HealthRX Medical Team examines her disclosure alongside other confirmed and speculated GLP-1 cases, and draws out the clinical lessons.
Read clinical reviewSharon Osbourne publicly confirmed using Ozempic, lost significant weight she called 'too much,' and discontinued. The HealthRX Medical Team breaks down the clinical timeline and what her experience reveals about GLP-1 risks in older adults.
Read clinical reviewSharon Osbourne publicly confirmed using Ozempic, then stopped after losing what she called a frightening amount of weight. The HealthRX Medical Team examines what clinical evidence says about GLP-1 discontinuation and weight regain in older adults.
Read clinical reviewSharon Osbourne publicly confirmed using Ozempic and later discontinuing it after excessive weight loss. Here's what her GLP-1 regimen would actually cost a non-celebrity patient navigating insurance, copays, and pharmacy realities.
Read clinical review